| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
| 05/29/2002 | CN1351507A Endoprosthesis with long-term stability |
| 05/29/2002 | CN1351503A Vaccine against streptococcus pneumoniae |
| 05/29/2002 | CN1351502A Multivaleng dengue virus vaccine |
| 05/29/2002 | CN1351501A Vaccine against antigens from bacteriae |
| 05/29/2002 | CN1351495A Liposome compositions for improved drugretention |
| 05/29/2002 | CN1351488A Drinkable pharmaceutical solution |
| 05/29/2002 | CN1350870A Chinese medicine for treating typhoid |
| 05/29/2002 | CN1350869A Medicine for treating hepatitis B virus |
| 05/29/2002 | CN1350868A Medicine for preventing and treating cold and its preparing process |
| 05/29/2002 | CN1350867A Compound oyster shell liquid |
| 05/29/2002 | CN1350863A Medicine for treating onychomycosis |
| 05/29/2002 | CN1085673C Phosphonate nucleotide compounds |
| 05/29/2002 | CN1085672C Phospholipid derivatives of phosphono-carboxylic acids, prodn, and use as antiviral |
| 05/29/2002 | CN1085537C Hog cholera treating medicine |
| 05/29/2002 | CN1085530C External use medicine for treating open wound |
| 05/29/2002 | CN1085528C Use of benzydamine in treatment of pathological conditions caused by TNF |
| 05/28/2002 | US6395879 Monoclonal antibodies against Campylobacter jejuni and Campylobacter coli outer membrane antigens |
| 05/28/2002 | US6395777 Ionic polymers as anti-infective agents |
| 05/28/2002 | US6395773 Anti-drug resistant strain agents and antichlamydia agents |
| 05/28/2002 | US6395767 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 05/28/2002 | US6395765 Parasiticides |
| 05/28/2002 | US6395754 Antiinflammatory agents, cardiovascular disorders, antipyretics |
| 05/28/2002 | US6395746 Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
| 05/28/2002 | US6395732 Bactericides |
| 05/28/2002 | US6395717 Sialic acid polymer |
| 05/28/2002 | US6395716 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B |
| 05/28/2002 | US6395710 Macrolide antiinfective agents |
| 05/28/2002 | US6395512 DNA coding for a peptide of a papilloma virus main capside protein and use thereof |
| 05/28/2002 | US6395497 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 05/28/2002 | US6395476 Evaluating long term outcome of viral disease infection; obtain sample, obtain viral nucleotide sequence from sample, screen sequences for presence of mutation in preferential codon, presence of mutation indicate more sever viral disease |
| 05/28/2002 | US6395474 Peptide nucleic acids |
| 05/28/2002 | US6395289 Hydrophilic polymer blends used to prevent cow skin infections |
| 05/28/2002 | US6395288 Fibrin sealant |
| 05/28/2002 | US6395275 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 05/28/2002 | CA2248006C Activated linkers and methods for making and purifying the same |
| 05/28/2002 | CA2121256C Secreted mac-2-binding glycoprotein |
| 05/28/2002 | CA2083274C The pharmacological use of certain cystine derivatives |
| 05/28/2002 | CA2073094C Germicidal compositions containing iodine compounds |
| 05/28/2002 | CA2048300C Compositions containing a 4-quinolone derivative complexed with a divalent metal ion |
| 05/23/2002 | WO2002040681A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 05/23/2002 | WO2002040678A1 Small acid-soluble spore protein and uses thereof |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040648A1 T cell line and use thereof |
| 05/23/2002 | WO2002040536A2 Acylated antimicrobial peptides |
| 05/23/2002 | WO2002040529A2 Diastereomeric peptides and pharmaceutical compositions comprising them |
| 05/23/2002 | WO2002040518A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 05/23/2002 | WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040516A2 Helicobacter cysteine rich protein a (hcpa) and uses thereof |
| 05/23/2002 | WO2002040511A2 Dna sequence and microcine from escherichia coli strain dsm 6601 |
| 05/23/2002 | WO2002040499A1 A method for generating genetically altered antigens |
| 05/23/2002 | WO2002040486A2 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS |
| 05/23/2002 | WO2002040483A1 1-methylcarbapenem derivatives |
| 05/23/2002 | WO2002040482A1 Process for producing carbapenem-type antibacterial |
| 05/23/2002 | WO2002040479A1 Anti-helicobacterial agents |
| 05/23/2002 | WO2002040474A2 Heterocyclylalkyl piperidine derivatives and their use as antimicrobial agents |
| 05/23/2002 | WO2002040472A1 Carbamoyl-bearing triazole fungicides |
| 05/23/2002 | WO2002040463A1 Macrocyclic compound |
| 05/23/2002 | WO2002040462A2 Cysteine protease inhibitors |
| 05/23/2002 | WO2002040450A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | WO2002040057A1 Antibiotics adducts with natural polysaccharide polymers in the form of aqueous solutions |
| 05/23/2002 | WO2002040051A1 Colostrum-based composition |
| 05/23/2002 | WO2002040046A1 Salmonella vaccine |
| 05/23/2002 | WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040028A1 Antibacterial gel eye drops |
| 05/23/2002 | WO2002040025A1 Anti-inflammatory agents |
| 05/23/2002 | WO2002040021A2 Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 05/23/2002 | WO2002040016A2 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 05/23/2002 | WO2002040013A1 Composition for stimulating the immune defence and iron metabolism, containing propionyl l-carnitine and lactoferrin |
| 05/23/2002 | WO2002039988A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 05/23/2002 | WO2002039963A1 Antifungal nail composition and method of use |
| 05/23/2002 | WO2002039953A2 Texaphyrin coordination compounds and uses thereof |
| 05/23/2002 | WO2002022612A8 Thiazolidine derivatives and its use as antifungal agent |
| 05/23/2002 | WO2002015931A9 Immunologic method for the prevention of dental caries |
| 05/23/2002 | WO2002006324A3 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 05/23/2002 | WO2002006213A3 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 05/23/2002 | WO2001097749A3 The use of synthetic, non-hormonal 21-aminosteroids and thereof |
| 05/23/2002 | WO2001096603A3 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 05/23/2002 | WO2001093846A3 Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans |
| 05/23/2002 | WO2001092253A3 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 05/23/2002 | WO2001085208A3 Molecular antigen arrays and vaccines |
| 05/23/2002 | WO2001085116A3 Synergistic antiplaque/antigingivitis oral composition |
| 05/23/2002 | WO2001083774A3 Novel mutated form of arginine deiminase |
| 05/23/2002 | WO2001083755A3 Human anti-cd40 antibodies and methods of making and using same |
| 05/23/2002 | WO2001082971A3 Cyclodextrin containing glycopeptide antibiotic compositions |
| 05/23/2002 | WO2001081373A3 Glycopeptide antibacterial compounds and methods of using same |
| 05/23/2002 | WO2001081340A3 Heterocycles that are inhibitors of impdh enzyme |
| 05/23/2002 | WO2001080839A3 Use of naphthindazole-4,9-quinones as antiparasitic agents |
| 05/23/2002 | WO2001080838A3 Use of n2-substituted benz[f]indazole-4,9-quinones as antiparasitic agents |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001079180A3 5-substituted tetralones as inhibitors of ras farnesyl transferase |
| 05/23/2002 | WO2001077687A3 Prion-binding peptidic ligands and methods of using same |
| 05/23/2002 | WO2001076637A3 Peptide conjugates for drug delivery |
| 05/23/2002 | WO2001074386A3 Cold-adapted equine influenza viruses |
| 05/23/2002 | WO2001072707A3 Carbamate caspase inhibitors and uses thereof |
| 05/23/2002 | WO2001072294A3 Method of treating hepatitis delta viral infection |
| 05/23/2002 | WO2001066097A3 Active substance directed against microbes of the genus pseudomonas |
| 05/23/2002 | WO2001053506A3 Virus strains for the oncolytic treatment of cancer |
| 05/23/2002 | WO2001049720A3 Chemically modified hiv envelope glycoprotein |